These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 1569162)

  • 21. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
    Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
    Bikle DD
    Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calciotropic hormones and bone markers in the elderly.
    Gallagher JC; Kinyamu HK; Fowler SE; Dawson-Hughes B; Dalsky GP; Sherman SS
    J Bone Miner Res; 1998 Mar; 13(3):475-82. PubMed ID: 9525348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-induced osteomalacia: clinical and basic studies.
    Shane E; Parisien M; Henderson JE; Dempster DW; Feldman F; Hardy MA; Tohme JF; Karaplis AC; Clemens TL
    J Bone Miner Res; 1997 Sep; 12(9):1502-11. PubMed ID: 9286768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteocalcin and bone alkaline phosphatase in the serum of women with liver disease.
    Steinberg KK; Bonkovsky HL; Caudill SP; Bernhardt RK; Hawkins M
    Ann Clin Lab Sci; 1991; 21(5):305-14. PubMed ID: 1952779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity.
    Mosekilde L; Melsen F; Hessov I; Christensen MS; Lund BJ; Lund BI; Sørensen OH
    Gut; 1980 Jul; 21(7):624-31. PubMed ID: 7429327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
    Andress DL; Maloney NA; Coburn JW; Endres DB; Sherrard DJ
    J Clin Endocrinol Metab; 1987 Jul; 65(1):11-6. PubMed ID: 3584392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
    Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
    Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs.
    Quarles LD; Dennis VW; Gitelman HJ; Harrelson JM; Drezner MK
    J Clin Invest; 1985 May; 75(5):1441-7. PubMed ID: 3998143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical parameters associated with low bone density in healthy men and women.
    Sherman SS; Tobin JD; Hollis BW; Gundberg CM; Roy TA; Plato CC
    J Bone Miner Res; 1992 Oct; 7(10):1123-30. PubMed ID: 1456082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in biochemical markers of osteoblastic activity during the menstrual cycle.
    Nielsen HK; Brixen K; Bouillon R; Mosekilde L
    J Clin Endocrinol Metab; 1990 May; 70(5):1431-7. PubMed ID: 2110577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticonvulsant osteomalacia in epileptic outpatients.
    Hoikka V; Savolainen K; Alhava EM; Sivenius J; Karjalainen P; Parvianinen M
    Ann Clin Res; 1982 Jun; 14(3):129-32. PubMed ID: 7137882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum osteocalcin and vitamin D in postmenopausal diabetic azotemics.
    Lu KC; Shieh SD; Chyr SH; Lin SH; Li BL; Diang LK; Chen WQ; Lin YF
    Diabetes Res; 1993; 22(3):97-104. PubMed ID: 8076446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between serum osteocalcin and 24,25-dihydroxyvitamin D levels in Paget's disease of bone.
    Castro-Errecaborde N; de la Piedra C; Rapado A; Alvarez-Arroyo MV; Torres R; Traba ML
    J Clin Endocrinol Metab; 1991 Feb; 72(2):462-6. PubMed ID: 1991815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D metabolism and osteomalacia in cystic fibrosis.
    Friedman HZ; Langman CB; Favus MJ
    Gastroenterology; 1985 Mar; 88(3):808-13. PubMed ID: 3871414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Osteocalcin and bone metabolism in rheumatoid arthritis and osteoarthritis].
    Franck H; van Valen F; Keck E; Krüskemper HL
    Z Rheumatol; 1986; 45(5):241-6. PubMed ID: 3492836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous 1alpha, 25[OH]2 vitamin D3 (calcitriol) pulse therapy for bone lesions in a murine model of chronic cadmium toxicosis.
    Kurata Y; Katsuta O; Hiratsuka H; Tsuchitani M; Umemura T
    Int J Exp Pathol; 2001 Feb; 82(1):43-53. PubMed ID: 11422540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.